The role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT).

Estephany Abou Jokh Casas,Nieves Martínez Lago,José Manuel Cabezas-Agrícola,Urbano Anido Herranz,F.J. Barón,Ovidio Fernandez Calvo,Maria Quindós-Varela,Silvia Varela Ferreiro,Alberto Carral Maseda,Jose Maria De Matias Leralta,Zulema Nogareda Seoane,Antia Cousillas Castiñeira,Sofía Rodríguez Martínez de Llano,José Antonio Mato Mato,Pablo Fernández Catalina,Omar Rodriguez Fonseca,Gloria Muñiz Garcia,Beatriz Bernardez,José Manuel Cameselle Teijeiro,Virginia Pubul Núñez

The role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT).

2021

371Background: Inflammation plays a key role in the pathophysiology of many diseases, including cancer. Systemic inflammatory factors have been validated as indicators of ongoing systemic inflammat...

Keywords:

inflammatory factors
peptide receptor
Cancer
Cancer research
Pathophysiology
radionuclide therapy
Neuroendocrine tumors
Inflammation
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations